Your browser doesn't support javascript.
Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
Chua, Kao-Ping; Conti, Rena M.
  • Chua KP; Susan B. Meister Child Health Evaluation and Research Center, Department of Pediatrics, University of Michigan Medical School, Ann Arbor.
  • Conti RM; Questrom School of Business, Institute for Health System Innovation and Policy, Department of Markets, Public Policy, and Law, Boston University, Boston, Massachusetts.
JAMA Intern Med ; 180(10): 1273-1274, 2020 10 01.
Article in English | MEDLINE | ID: covidwho-718290

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Orphan Drug Production / Pneumonia, Viral / Adenosine Monophosphate / Coronavirus Infections / Alanine Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Intern Med Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Orphan Drug Production / Pneumonia, Viral / Adenosine Monophosphate / Coronavirus Infections / Alanine Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Intern Med Year: 2020 Document Type: Article